stockrow
Friday 6 November 2026
Export EWTX’s income statement to Excel — free account
Edgewise Therapeutics, Inc.
EWTX Healthcare Biotechnology
- EPS
- +2,846.5%
- Free cash flow
- −30.2%
Quarter to September 2026, against a year earlier
44.89
6.02
+15.49%
Follow EWTX
Alert me
Edgewise Therapeutics, Inc. (EWTX) Book value per share
Edgewise Therapeutics, Inc.'s book value per share at the end of fiscal 2025 was 5.1×, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was 15.0×. Over the past ten years it has ranged from 5.0× (fiscal 2024) to 172× (fiscal 2020); the current reading is higher than 50% of that period. Edgewise Therapeutics, Inc. ranks 175th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 5.1× | 2.11% |
| FY2024 | 5.0× | (0.68%) |
| FY2023 | 5.0× | (22.66%) |
| FY2022 | 6.5× | (11.52%) |
| FY2021 | 7.3× | (95.74%) |
| FY2020 | 172× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Sep 2026 | 15.0× | 260.35% |
| Jun 2026 | 4.2× | (9.61%) |
| Mar 2026 | 4.6× | (9.26%) |
| Dec 2025 | 5.1× | (4.19%) |
| 23 more quarters | Free account |
Against its own ten years
Low 5.0×
High 172×
Ten-year median
5.8×
Current reading's percentile
50
Book value per share against peers
| Company | Book value per share |
|---|---|
| XENE Xenon Pharmaceuticals Inc. compare | 12.5× |
| DFTX Definium Therapeutics, Inc. compare | 8.3× |
| TNGX Tango Therapeutics, Inc. compare | 6.8× |
| LEGN Legend Biotech Corporation Sponsored ADR compare | 6.6× |
| RLAY Relay Therapeutics, Inc. compare | 4.4× |
| EWTX Edgewise Therapeutics, Inc. | 4.2× |
| ABCL AbCellera Biologics Inc. compare | 2.9× |
| ARQT Arcutis Biotherapeutics, Inc. compare | 0.0× |
| IOVA Iovance Biotherapeutics, Inc. compare | 0.0× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))